Keiichi Hanaki, Tomoe Kinoshita, Masanobu Fujimoto, Yuki Sonoyama-kawashima, Susumu Kanzaki, Noriyuki Namba. Alström Syndrome: A Review Focusing on Its Diverse Clinical Manifestations and Their Etiology as a Ciliopathy. Yonago Acta Medica. 2024
Yuki Kawashima-Sonoyama, Keisuke Wada, Kei Yamamoto, Masanobu Fujimoto, Noriyuki Namba, Takeshi Taketani. Clinical characteristics of and growth hormone treatment effects on short stature with type 1 insulin-like growth factor receptor (IGF1R) gene alteration. Endocrine journal. 2024
Avinaash V Maharaj, Emily Cottrell, Thatchawan Thanasupawat, Sjoerd D Joustra, Barbara Triggs-Raine, Masanobu Fujimoto, Sarina G Kant, Danielle van der Kaay, Agnes Clement-de Boers, Alice S Brooks, et al. Characterization of HMGA2 variants expands the spectrum of Silver-Russell syndrome. JCI insight. 2024. 9. 6
Yuichiro Hashida, Yoichi Mino, Keisuke Okuno, Hitoshi Uemasu, Shinji Sakata, Masanobu Fujimoto, Noriyuki Namba. Thyroid hormone may predict treatment failure in Kawasaki disease. Pediatrics international : official journal of the Japan Pediatric Society. 2024. 66. 1. e15723
Shintaro Senoo, Masanobu Fujimoto, Yukiko Yamaguchi, Mari Osaki, Keiichi Hanaki, Noriyuki Namba. Switching to burosumab from conventional therapy in siblings with relatively well-controlled X-linked hypophosphatemia. Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology. 2024. 33. 1. 27-34
